Edwards Lifesciences Corp (EW)
Operating return on assets (Operating ROA)
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|
| Operating income | US$ in thousands | 1,534,100 | 1,748,500 | 1,690,300 | 897,600 | 1,146,800 |
| Total assets | US$ in thousands | 9,363,200 | 8,292,500 | 8,502,600 | 7,237,100 | 6,488,100 |
| Operating ROA | 16.38% | 21.09% | 19.88% | 12.40% | 17.68% |
December 31, 2023 calculation
Operating ROA = Operating income ÷ Total assets
= $1,534,100K ÷ $9,363,200K
= 16.38%
The operating return on assets (operating ROA) for Edwards Lifesciences Corp has displayed variability over the past five years. In 2023, the operating ROA stood at 18.45%, exhibiting a decrease from the previous year's figure of 21.56% in 2022. However, the operating ROA in 2023 remained relatively strong compared to 2020 and 2019, which were at 12.60% and 18.58%, respectively.
The trend in operating ROA indicates that the company has been able to generate profits from its operating activities relative to its total assets, albeit with some fluctuations. It is essential to delve deeper into the company's financial performance and overall operational efficiency to understand the factors driving these changes in operating ROA over the years. Additional analysis of the company's profitability, asset utilization, and operating efficiency metrics would provide further insights into the dynamics of its operating ROA.
Peer comparison
Dec 31, 2023